Bill · started in the Commons

Brain Tumours Bill

A Bill to set a target for the number of glioblastoma patients who take part in clinical trials each year; to require training for medical oncologists to include training relating to brain cancers; to provide that any drug that has been licensed for use on tumours must be trialled on people with brain tumours; to make provision in relation to neuro-oncology multidisciplinary teams in the NHS, including a requirement that each such team must include a medical oncologist; to require manufacturers of drugs licensed to treat tumours to make those drugs available in specified circumstances for clinical trials relating to brain tumours; and for connected purposes.

The story so farThe Brain Tumours Bill was introduced in the House of Commons on 18 October 2023 by Siobhain McDonagh (Labour). It is now at first reading in the House of Commons. First reading is the formal introduction, with no debate; the substantive debate comes at second reading.

Progress through Parliament

Source: the official bill page. Last updated 31 Oct 2023.